Target intelligence / Profile preview

Extracellular matrix restoration

Molecular classification
Other
01

Overview

Extracellular matrix restoration is not a discrete molecular target, but rather the therapeutic goal of repairing or regenerating the ECM, which is a dynamic and complex network of proteins (collagen, elastin, fibronectin, laminin), proteoglycans, and glycosaminoglycans that provides both structural integrity to tissues and essential signaling environments for cellular adhesion, migration, proliferation, and differentiation. ECM restoration is critical in wound healing, surgical recovery, tissue engineering, and diseases characterized by abnormal tissue repair or remodeling. Therapeutic approaches target the balance between ECM synthesis and degradation, aiming to restore or approximate the native architecture and biomechanical properties of healthy tissues, reduce pathological scarring/fibrosis, and optimize tissue function and regeneration.

Other names
ECM restorationextracellular matrix repairmatrix regeneration
02

Mechanism of action

Inhibition of ECM degradation (e.g., MMP inhibitors); Promotion of new ECM synthesis (e.g., collagen promoters, growth factors); Mechanical stimulation/modulation; Use of scaffolds to provide ECM structure and cues for cell infiltration and repair

03

Biological functions

Tissue support/structural integrityCell adhesionRegulation of migration, proliferation, and differentiationWound healing and regenerationStorage and presentation of growth factors/cytokinesModulation of cell signaling
04

Disease associations

Cancer (ECM degradation is key in metastasis)Fibrosis and chronic wounds (maladaptive ECM restoration)Cardiovascular disease (remodeling after injury)InflammationNeurodegenerative disease (ECM changes impact neural integrity)
05

Safety considerations

Excessive matrix deposition (fibrosis, scar tissue formation)Insufficient matrix remodeling (chronic wounds, impaired healing)Immunogenicity/allergy with biomaterials (e.g., decellularized ECM implants)Aberrant tissue regeneration (contractures, adhesions)
06

Interacting drugs

Matrix metalloproteinase inhibitors (MMP inhibitors)

4 more in the full profile.

07

Biomarkers

Collagen content or turnover (hydroxyproline, procollagen peptides)Matrix metalloproteinase (MMP) activityFibronectin or laminin levelsScar architecture/scarring indices

Beyond the preview

Go deeper on Extracellular matrix restoration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix restoration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call